Epicrispr Biotechnologies, Inc.

New Filing
CIK: 0002151604·Biotechnology·DELAWARE·Filed: Aug 25, 2026
Total Offering

$212,755,230

Amount Sold

$176,754,406

Investors

47

First Sale

May 4, 2018

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Amber Salzman
Haorui Zhang
Lei Qi
Andrew Lam
Jennifer King
Eric Crombez
Anran Li

Company

Epicrispr Biotechnologies, Inc.

7000 SHORELINE COURT, STE 100

SOUTH SAN FRANCISCO, CA, 94080

510-934-7574

SEC Filing

0002151604-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Epicrispr Biotechnologies, Inc. Form D Filing — $212,755,230 | FilingFlow